The global primary biliary cholangitis (PBC) therapeutics market is expected to witness substantial growth, expanding at a CAGR of 10.50% during 2025–2034. The surge is primarily driven by increasing awareness initiatives aimed at early diagnosis and prevention of complications associated with this chronic liver condition. As global healthcare systems emphasize early intervention, the... https://www.expertmarketresearch.com/reports/primary-biliary-cholangitis-therapeutics-market